Last Updated: July 6, 2026

TETRACAINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Tetracaine

A generic version of TETRACAINE was approved as tetracaine hydrochloride by ALCON LABS on February 29th, 2016.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TETRACAINE?
  • What are the global sales for TETRACAINE?
  • What is Average Wholesale Price for TETRACAINE?
Summary for TETRACAINE
US Patents:0
Applicants:3
NDAs:3
Drug Prices: Drug price information for TETRACAINE
DailyMed Link:TETRACAINE at DailyMed

US Patents and Regulatory Information for TETRACAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 208135-001 Feb 29, 2016 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bausch Lomb Ireland TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 210821-001 Mar 12, 2019 AB1 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset Theraps Llc TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 217227-001 Dec 20, 2024 AB1 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.